Manus — the Chinese AI agent startup that demonstrated viral multi-step automation capabilities in early 2025 and briefly led international agent benchmarks — is raising $500 million at a $4 billion valuation after one of the most consequential deal collapses in AI's short M&A history. Meta acquired Manus in December 2025 for $2 billion, when the company was generating more than $100 million in annual recurring revenue. Beijing blocked the deal in April 2026, citing concerns about AI talent emigrating to the United States and potential export-control violations. After months unwinding Meta's ownership stake — a process that required buying back shares at a premium from investors who had priced in the acquisition — Manus resumed independent operations in September. The new round is backed by IDG Capital, Boyu Capital, and Contemporary Amperex Technology (CATL) — the world's largest electric vehicle battery manufacturer — alongside existing investors Tencent, HSG, and ZhenFund.
The $4 billion target is double the price early investors paid to repurchase shares after the deal collapsed, validating the AI agent category's resilience independent of US Big Tech acquisition. CATL's participation is the more structurally significant element: the company manufactures batteries for nearly every major EV platform globally, operates industrial environments where physical AI agents have direct deployment pathways, and has strategic rationale for investing in an agentic AI platform at the scale where industrial automation meets AI agent capability.
Beijing's ability to block the Meta acquisition — overriding a $2 billion deal both parties had agreed to — establishes that China treats its leading AI agent startups as national strategic infrastructure. The combination of the Manus block and the new round's Chinese industrial capital base signals a deliberate architecture: Chinese AI agent capability stays inside Chinese capital structures, with access to industrial deployment through companies like CATL, rather than being absorbed into US Big Tech R&D pipelines.